Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity (Q40560543)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2004

Language	Label	Description	Also known as
English	Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity	scientific article published on May 2004

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity (English)

1 reference

Europe PubMed Central

21 September 2017

Japanese encephalitis virus

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

21 September 2017

7

object named as

Huanchun Chen

1 reference

Europe PubMed Central

21 September 2017

author name string

Gaoyuan Xu

1

1 reference

Europe PubMed Central

21 September 2017

Xiaojuan Xu

2

1 reference

Europe PubMed Central

21 September 2017

Zili Li

3

1 reference

Europe PubMed Central

21 September 2017

Qigai He

4

1 reference

Europe PubMed Central

21 September 2017

Shengfu Sun

6

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

22

1 reference

Europe PubMed Central

21 September 2017

15-16

1 reference

Europe PubMed Central

21 September 2017

1846-1853

1 reference

Europe PubMed Central

21 September 2017

Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Flavivirus genome organization, expression, and replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

The development and application of the latex agglutination test to detect serum antibodies against Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Site-specific insertion of DNA into a pseudorabies virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Pseudorabies virus as a live virus vector for expression of foreign genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.015

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.09.015

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40560543&oldid=1900567335"